Martin Shkreli Raises Daraprim Price by 5,000%, From $13.50 to $750 Per Pill

In September 2015, Turing Pharmaceuticals under CEO Martin Shkreli purchased the American marketing rights to Daraprim (pyrimethamine) and immediately raised the price from $13.50 to $750 per pill—a price increase of over 5,000%. The move became a symbol of pharmaceutical price gouging and exposed …